ANTITUMOR MECHANISMS OF 3'-ETHYNYLURIDINE AND 3'-ETHYNYLCYTIDINE AS RNA-SYNTHESIS INHIBITORS - DEVELOPMENT AND CHARACTERIZATION OF 3'-ETHYNYLURIDINE-RESISTANT CELLS
S. Tabata et al., ANTITUMOR MECHANISMS OF 3'-ETHYNYLURIDINE AND 3'-ETHYNYLCYTIDINE AS RNA-SYNTHESIS INHIBITORS - DEVELOPMENT AND CHARACTERIZATION OF 3'-ETHYNYLURIDINE-RESISTANT CELLS, Cancer letters, 116(2), 1997, pp. 225-231
To discover the mechanisms of anti-tumor action of 3'-ethynyluridine (
EUrd) and 3'-ethynylcytidine (ECyd), we established an EUrd-resistant
variant from human fibrosarcoma HT-1080 cells. The cells were cross-re
sistant to ECyd. Uridine/cytidine kinase activity diminished in the re
sistant cells. The incorporation of EUrd and ECyd into the RNA fractio
n in the resistant cells was less than that of the parental cells. EUr
d-triphosphate inhibited RNA synthesis by human RNA polymerase II. The
results led us to conclude that EUrd and ECyd are phosphorylated by u
ridine/cytidine kinase to 5'-triphosphates, and that their triphosphat
es might inhibit RNA polymerase. (C) 1997 Elsevier Science Ireland Ltd
.